MFT
VRTX icon

Moisand Fitzgerald Tamayo’s Vertex Pharmaceuticals VRTX Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.3K Hold
200
– – 0.01% 163
2026
Q1 		$89.3K Hold
200
– – 0.01% 161
2025
Q4 		$90.7K Hold
200
– – 0.01% 155
2025
Q3 		$78.3K Hold
200
– – 0.01% 161
2025
Q2 		$89K Hold
200
– – 0.01% 155
2025
Q1 		$97K Hold
200
– – 0.01% 149
2024
Q4 		$80.5K Hold
200
– – 0.01% 154
2024
Q3 		$93K Hold
200
– – 0.01% 152
2024
Q2 		$93.7K Hold
200
– – 0.01% 137
2024
Q1 		$83.6K Hold
200
– – 0.01% 145
2023
Q4 		$81.4K Hold
200
– – 0.01% 142
2023
Q3 		$69.5K Hold
200
– – 0.01% 153
2023
Q2 		$70.4K Hold
200
– – 0.01% 148
2023
Q1 		$63K Buy
200
+166
+488% +$49.8K 0.01% 157
2022
Q4 		$9.82K Buy
34
+15
+79% +$4.57K ﹤0.01% 317
2022
Q3 		$6K Buy
+19
New +$5.47K ﹤0.01% 351

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Moisand Fitzgerald Tamayo's VRTX Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 200 shares worth $99.3K. The position accounts for 0.01% of the portfolio, ranked #163.

Moisand Fitzgerald Tamayo first reported a position in VRTX in Q3 2022 and has held it in 16 quarters since. 299 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Moisand Fitzgerald Tamayo held 200 shares of Vertex Pharmaceuticals worth $99.3K as of Q2 2026.
  • Moisand Fitzgerald Tamayo left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #163 holding.
  • Moisand Fitzgerald Tamayo first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 299 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.